Diagnostic Value of <sup>18</sup>F-FDG-PET/CT in Patients with FUO

Conventional diagnostic imaging is often ineffective in revealing the underlying cause in a considerable proportion of patients with fever of unknown origin (FUO). The aim of this study was to assess the diagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomogra...

Full description

Bibliographic Details
Main Authors: Stamata Georga, Paraskevi Exadaktylou, Ioannis Petrou, Dimitrios Katsampoukas, Vasilios Mpalaris, Efstratios-Iordanis Moralidis, Kostoula Arvaniti, Christos Papastergiou, Georgios Arsos
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/9/7/2112
_version_ 1797563319745249280
author Stamata Georga
Paraskevi Exadaktylou
Ioannis Petrou
Dimitrios Katsampoukas
Vasilios Mpalaris
Efstratios-Iordanis Moralidis
Kostoula Arvaniti
Christos Papastergiou
Georgios Arsos
author_facet Stamata Georga
Paraskevi Exadaktylou
Ioannis Petrou
Dimitrios Katsampoukas
Vasilios Mpalaris
Efstratios-Iordanis Moralidis
Kostoula Arvaniti
Christos Papastergiou
Georgios Arsos
author_sort Stamata Georga
collection DOAJ
description Conventional diagnostic imaging is often ineffective in revealing the underlying cause in a considerable proportion of patients with fever of unknown origin (FUO). The aim of this study was to assess the diagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (<sup>18</sup>F-FDG-PET/CT) in patients with FUO. We retrospectively reviewed <sup>18</sup>F-FDG-PET/CT scans performed on 50 consecutive adult patients referred to our department for further investigation of classic FUO. Final diagnosis was based on histopathological and microbiological findings, clinical criteria, or clinical follow-up. Final diagnosis was established in 39/50 (78%) of the patients. The cause of FUO was infection in 20/50 (40%), noninfectious inflammatory diseases in 11/50 (22%), and malignancy in 8/50 (16%) patients. Fever remained unexplained in 11/50 (22%) patients. <sup>18</sup>F-FDG-PET/CT scan substantially contributed to the diagnosis in 70% of the patients, either by identifying the underlying cause of FUO or by directing to the most appropriate site for biopsy. Sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV) of <sup>18</sup>F-FDG-PET/CT for active disease detection in patients with FUO were 94.7%, 50.0%, 84.0%, 85.7%, and 75.0%, respectively. In conclusion, whole-body <sup>18</sup>F-FDG-PET/CT is a highly sensitive method for detection of the underlining cause of FUO or for correctly targeting suspicious lesions for further evaluation.
first_indexed 2024-03-10T18:40:59Z
format Article
id doaj.art-d484e21cf8c64b6e82ad9c1ec8a55d38
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T18:40:59Z
publishDate 2020-07-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-d484e21cf8c64b6e82ad9c1ec8a55d382023-11-20T05:52:35ZengMDPI AGJournal of Clinical Medicine2077-03832020-07-0197211210.3390/jcm9072112Diagnostic Value of <sup>18</sup>F-FDG-PET/CT in Patients with FUOStamata Georga0Paraskevi Exadaktylou1Ioannis Petrou2Dimitrios Katsampoukas3Vasilios Mpalaris4Efstratios-Iordanis Moralidis5Kostoula Arvaniti6Christos Papastergiou7Georgios Arsos83rd Department of Nuclear Medicine, Aristotle University of Thessaloniki Medical School, Papageorgiou General Hospital, 56403 Thessaloniki, Greece3rd Department of Nuclear Medicine, Aristotle University of Thessaloniki Medical School, Papageorgiou General Hospital, 56403 Thessaloniki, Greece3rd Department of Nuclear Medicine, Aristotle University of Thessaloniki Medical School, Papageorgiou General Hospital, 56403 Thessaloniki, Greece3rd Department of Nuclear Medicine, Aristotle University of Thessaloniki Medical School, Papageorgiou General Hospital, 56403 Thessaloniki, Greece3rd Department of Nuclear Medicine, Aristotle University of Thessaloniki Medical School, Papageorgiou General Hospital, 56403 Thessaloniki, Greece3rd Department of Nuclear Medicine, Aristotle University of Thessaloniki Medical School, Papageorgiou General Hospital, 56403 Thessaloniki, GreeceICU and Antimicrobial Stewardship Unit, Papageorgiou General Hospital, 56403 Thessaloniki, GreeceDepartment of Radiology, Papageorgiou General Hospital, 56403 Thessaloniki, Greece3rd Department of Nuclear Medicine, Aristotle University of Thessaloniki Medical School, Papageorgiou General Hospital, 56403 Thessaloniki, GreeceConventional diagnostic imaging is often ineffective in revealing the underlying cause in a considerable proportion of patients with fever of unknown origin (FUO). The aim of this study was to assess the diagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (<sup>18</sup>F-FDG-PET/CT) in patients with FUO. We retrospectively reviewed <sup>18</sup>F-FDG-PET/CT scans performed on 50 consecutive adult patients referred to our department for further investigation of classic FUO. Final diagnosis was based on histopathological and microbiological findings, clinical criteria, or clinical follow-up. Final diagnosis was established in 39/50 (78%) of the patients. The cause of FUO was infection in 20/50 (40%), noninfectious inflammatory diseases in 11/50 (22%), and malignancy in 8/50 (16%) patients. Fever remained unexplained in 11/50 (22%) patients. <sup>18</sup>F-FDG-PET/CT scan substantially contributed to the diagnosis in 70% of the patients, either by identifying the underlying cause of FUO or by directing to the most appropriate site for biopsy. Sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV) of <sup>18</sup>F-FDG-PET/CT for active disease detection in patients with FUO were 94.7%, 50.0%, 84.0%, 85.7%, and 75.0%, respectively. In conclusion, whole-body <sup>18</sup>F-FDG-PET/CT is a highly sensitive method for detection of the underlining cause of FUO or for correctly targeting suspicious lesions for further evaluation.https://www.mdpi.com/2077-0383/9/7/2112fever of unknown originFUOPET/CT<sup>18</sup>F-FDG-PET/CT
spellingShingle Stamata Georga
Paraskevi Exadaktylou
Ioannis Petrou
Dimitrios Katsampoukas
Vasilios Mpalaris
Efstratios-Iordanis Moralidis
Kostoula Arvaniti
Christos Papastergiou
Georgios Arsos
Diagnostic Value of <sup>18</sup>F-FDG-PET/CT in Patients with FUO
Journal of Clinical Medicine
fever of unknown origin
FUO
PET/CT
<sup>18</sup>F-FDG-PET/CT
title Diagnostic Value of <sup>18</sup>F-FDG-PET/CT in Patients with FUO
title_full Diagnostic Value of <sup>18</sup>F-FDG-PET/CT in Patients with FUO
title_fullStr Diagnostic Value of <sup>18</sup>F-FDG-PET/CT in Patients with FUO
title_full_unstemmed Diagnostic Value of <sup>18</sup>F-FDG-PET/CT in Patients with FUO
title_short Diagnostic Value of <sup>18</sup>F-FDG-PET/CT in Patients with FUO
title_sort diagnostic value of sup 18 sup f fdg pet ct in patients with fuo
topic fever of unknown origin
FUO
PET/CT
<sup>18</sup>F-FDG-PET/CT
url https://www.mdpi.com/2077-0383/9/7/2112
work_keys_str_mv AT stamatageorga diagnosticvalueofsup18supffdgpetctinpatientswithfuo
AT paraskeviexadaktylou diagnosticvalueofsup18supffdgpetctinpatientswithfuo
AT ioannispetrou diagnosticvalueofsup18supffdgpetctinpatientswithfuo
AT dimitrioskatsampoukas diagnosticvalueofsup18supffdgpetctinpatientswithfuo
AT vasiliosmpalaris diagnosticvalueofsup18supffdgpetctinpatientswithfuo
AT efstratiosiordanismoralidis diagnosticvalueofsup18supffdgpetctinpatientswithfuo
AT kostoulaarvaniti diagnosticvalueofsup18supffdgpetctinpatientswithfuo
AT christospapastergiou diagnosticvalueofsup18supffdgpetctinpatientswithfuo
AT georgiosarsos diagnosticvalueofsup18supffdgpetctinpatientswithfuo